Search clinical trials for: MT1621
Total 12 results
-
Zogenix MDS, Inc.Zogenix, Inc.WithdrawnThymidine Kinase 2 Deficiency
-
UCB BIOSCIENCES, Inc.Zogenix, Inc.Active, not recruitingThymidine Kinase 2 DeficiencyUnited States, Israel, Spain
-
Vigeo Therapeutics, Inc.Active, not recruiting
-
Mthera Pharma Co., Ltd.Not yet recruiting
-
Medy-ToxCompletedSubmental FatKorea, Republic of
-
Medy-ToxCompletedSubmental FatKorea, Republic of
-
Mthera Pharma Co., Ltd.Amarex Clinical ResearchCompletedParkinson's DiseaseUnited States
-
AmgenMedImmune LLCTerminatedGI AdenocarcinomaGermany, Netherlands
-
Medy-ToxCompletedPharmacokinetic/Pharmacodynamic Characteristics and Safety/Tolerability of MT921 in Healthy SubjectsHealthy VolunteersKorea, Republic of
-
Forest LaboratoriesCompletedCystic Fibrosis | Pancreatic InsufficiencyUnited States
-
Thar Pharmaceuticals, IncCompletedHealthy Postmenopausal WomenUnited States
-
Global Coalition for Adaptive ResearchBayer; Kazia Therapeutics Limited; Biohaven Pharmaceuticals, Inc.; Kintara Therapeutics... and other collaboratorsRecruitingGlioblastomaUnited States, France, Germany, Canada, Australia, Switzerland